Patanjali Ayurved

But other modes like OFS, QIP to raise public shareholding

Patanjali Foods Ltd, which is mainly into edible oil business, has posted a 15 per cent growth in its net profit to Rs 269.18 crore for the December quarter on better sales. Its net profit stood at Rs 234.07 crore in the year-ago period, according to a regulatory filing. Total income rose by 26 per cent to Rs 7,963.75 crore during the quarter ended December 31, as compared to Rs 6,301.19 crore in the corresponding period of the previous year. During the April-December period of this fiscal, nine-month period ended December 31, 2022, net profit increased to Rs 622.73 crore from Rs 571.87 crore a year ago, said Patanjali Foods, which is part of Baba Ramdev-led Patanjali Ayurved. Total income rose to Rs 23,858.50 crore in the first nine months of this fiscal year from Rs 17,608.18 crore in the previous year. Patanjali Foods Ltd (formerly known as Ruchi Soya Industries Ltd), has 25 manufacturing facilities, and an allocation of 6.23 lakh hectares of oil palm plantation. Besides edibl

Firm to focus on new launches with high margins and high growth

Patanjali also plans to carry out oil palm plantations on over 1.5 mn acres in 55 districts of 11 states, and aims to earn annual returns of Rs 2,000 crore in five to seven years

Other FMCG companies will have to increase their advertising spends in segments Reliance makes a meaningful acquisition in order to stay competitive.

In May, Ruchi Soya announced the acquisition of Patanjali Ayurved's entire food business for Rs 690 crore, in order to speed up its transition into an FMCG company

To pay 1% of turnover of products as annual royalty under transfer agreement

The board also approved to change company's name from Ruchi Soya Industries to Patanjali Foods.

The board of Ruchi Soya also accorded its in-principle approval for evaluating the most efficient mode of enhancing synergies with Patanjali Ayurved Ltd's food portfolio on an arm's-length basis

Edible oil firm Ruchi Soya, which is owned by Baba Ramdev-led Patanjali Ayurved, will hit the capital market with its follow-on public offer (FPO) on March 24 to raise up to Rs 4,300 cr.

Ruchi Soya to use FPO fund to repay debt

Patanjali Yogpeeth Trust denied allegations by the Indian Medical Association (IMA) that yoga guru Ramdev has misled people by making "unlearned" statements modern medicine

Baba Ramdev-led Patanjali Ayurved on Tuesday said it has raised Rs 175 crore by issuing non-convertible debentures (NCDs).

To support its argument, Patanjali has released a bunch of scientific papers on its research for a Covid-19 medicine that was published in popular peer-reviewed journals

The firm said its Coronil tablet has received certification from the Ayush Ministry as a medicine supporting COVID-19 treatment as per the World Health Organization's certification scheme

Ramdev, partner see biggest jump in wealth in percentage terms

Ruchi Soya Industries Ltd in a notice to shareholders sought approval for appointment of Ram Bharat, 41, as the managing director of the company.

While the company's operating revenue grew 6%, net profit jumped 22% in FY2020

Total expenses of Patanjali Ayurved were up 5.34 per cent to Rs 8,521.44 crore

Baba Ramdev's fame drives Patanjali - he evolves broad strategies and Acharya Balkrishna acts as MD. But there is also a third man in Patanjali's power index: Ram Bharat, Ramdev's younger brother